Did everyone get what they expected from the Fed today? Gather around as papa Bernanke tells a story regarding the state of the economy. Why does this guy remind me of the bad Santa, north pole Santa’s evil twin? Rather than making and distributing toys, this guy looks to be making the elves print and stash away tonnes of cash.
Of the 671 stocks analyzed on the S&P 500 and TSE 362 advanced, 299 declined and the remaining 10 passed out after story-time. Still over half of stocks, at 52.6%, are below their 50-day moving average.
Today’s report highlights all of the stocks that made a Bullish Moving Average Crossover, indicated a Bullish Centerline Crossover with respect to RSI, AND are listed as Neutral under stochastics.
Highlighting: ALLERGAN INC (NYSE:AGN), BARD C R INC (NYSE:BCR), CIGNA CP (NYSE:CI), DAVITA INC (NYSE:DVA)
| ALLERGAN INC (AGN) | ||||||||
| 57.82 | + 1.46 (2.59%) | |||||||
| Support 2 | Support 1 | Pivot Point | Resistance 1 | Resistance 2 | ||||
| 55.41 | 56.61 | 57.55 | 58.75 | 59.69 | ||||
| Support & Resistance Analysis | Broke Lwr Resistance (1) | |||||||
| MACD Analysis | Bullish Centreline Crossover | MACD | ||||||
| MACD vs. Signal | Bullish MA Crossover | 0.017 | ||||||
| RSI Analysis | Bullish Centerline Crossover | RSI | ||||||
| Stochastic (Fast) Analysis | Neutral | 55.281 | ||||||
| 50-Day MA Analysis | Above 50-Day MA | %K (fast) | ||||||
| 200-Day MA Analysis | Above 200-Day MA | 79.929 | ||||||
| Critical Level Analysis | ||||||||
| ALLERGAN INC (AGN) Seasonality | ||||||||
| Analysis has revealed that with a buy date of October 25 and a sell date of September 14, investors have benefited from a total return of 304.69% over the last 10 years. This scenario has shown positive results in 6 of those periods. | ||||||||
| Conversely, the best return over the maximum number of positive periods reveals a buy date of April 14 and a sell date of June 19, producing a total return over the same 10-year range of 127.18% with positive results in 10 of those periods. | ||||||||
| The buy and hold return for the past 10 years was 129.63%. | ||||||||
| News Headlines for ALLERGAN INC (AGN) | ||||||||
Wall Street rises on bank deal speculation (at FT.com) - Wed, 10 Mar 2010 BOTOX® (OnabotulinumtoxinA) Receives FDA Approval for Treatment of Upper Limb Spasticity in Adults (Business Wire) - Wed, 10 Mar 2010 FDA approves Botox for elbow, wrist, finger spasms (AP) - Tue, 9 Mar 2010 |
||||||||
| BARD C R INC (BCR) | ||||||||
| 76.99 | + 1.25 (1.65%) | |||||||
| Support 2 | Support 1 | Pivot Point | Resistance 1 | Resistance 2 | ||||
| 75.68 | 76.33 | 77.06 | 77.71 | 78.44 | ||||
| Support & Resistance Analysis | Broke Upr Resistance (2) | |||||||
| MACD Analysis | Negative/Increasing | MACD | ||||||
| MACD vs. Signal | Bullish MA Crossover | -0.480 | ||||||
| RSI Analysis | Bullish Centerline Crossover | RSI | ||||||
| Stochastic (Fast) Analysis | Neutral | 52.161 | ||||||
| 50-Day MA Analysis | Below 50-Day MA | %K (fast) | ||||||
| 200-Day MA Analysis | Above 200-Day MA | 79.156 | ||||||
| Critical Level Analysis | ||||||||
| BARD C R INC (BCR) Seasonality | ||||||||
| Analysis has revealed that with a buy date of January 26 and a sell date of January 2, investors have benefited from a total return of 489.47% over the last 10 years. This scenario has shown positive results in 9 of those periods. | ||||||||
| Conversely, the best return over the maximum number of positive periods reveals a buy date of March 12 and a sell date of September 11, producing a total return over the same 10-year range of 206.37% with positive results in 10 of those periods. | ||||||||
| The buy and hold return for the past 10 years was 206.98%. | ||||||||
| News Headlines for BARD C R INC (BCR) | ||||||||
Coverage initiated on C.R. Bard by Morgan Joseph (Briefing.com) - Wed, 10 Mar 2010 BARD C R INC /NJ/ Financials (EDGAR Online Financials) - Wed, 3 Mar 2010 Covidien Happy With Tyco Split (at Investopedia) - Wed, 3 Mar 2010 |
||||||||
| CIGNA CP (CI) | ||||||||
| 29.78 | + 1.47 (5.19%) | |||||||
| Support 2 | Support 1 | Pivot Point | Resistance 1 | Resistance 2 | ||||
| 28.13 | 28.96 | 29.97 | 30.80 | 31.81 | ||||
| Support & Resistance Analysis | Broke Upr Resistance (2) | |||||||
| MACD Analysis | Negative/Increasing | MACD | ||||||
| MACD vs. Signal | Bullish MA Crossover | -0.188 | ||||||
| RSI Analysis | Bullish Centerline Crossover | RSI | ||||||
| Stochastic (Fast) Analysis | Neutral | 55.179 | ||||||
| 50-Day MA Analysis | Above 50-Day MA | %K (fast) | ||||||
| 200-Day MA Analysis | Above 200-Day MA | 68.074 | ||||||
| Critical Level Analysis | Broke Above Previous Trend | |||||||
| CIGNA CP (CI) Seasonality | ||||||||
| Analysis has revealed that with a buy date of November 21 and a sell date of September 14, investors have benefited from a total return of 699.03% over the last 10 years. This scenario has shown positive results in 7 of those periods. | ||||||||
| Conversely, the best return over the maximum number of positive periods reveals a buy date of March 21 and a sell date of April 5, producing a total return over the same 10-year range of 84.11% with positive results in 10 of those periods. | ||||||||
| The buy and hold return for the past 10 years was 24.34%. | ||||||||
| News Headlines for CIGNA CP (CI) | ||||||||
Krugman Smells Victory for Healthcare (at Seeking Alpha) - Wed, 10 Mar 2010 Toyota: Analysts' Upgrades, Downgrades (at TheStreet.com) - Tue, 9 Mar 2010 CIGNA CORP Files SEC form 8-K, Regulation FD Disclosure (EDGAR Online) - Mon, 8 Mar 2010 |
||||||||
| DAVITA INC (DVA) | ||||||||
| 57.93 | + 3.53 (6.49%) | |||||||
| Support 2 | Support 1 | Pivot Point | Resistance 1 | Resistance 2 | ||||
| 54.14 | 56.04 | 57.98 | 59.88 | 61.82 | ||||
| Support & Resistance Analysis | Broke Upr Resistance (2) | |||||||
| MACD Analysis | Negative/Increasing | MACD | ||||||
| MACD vs. Signal | Bullish MA Crossover | -0.117 | ||||||
| RSI Analysis | Bullish Centerline Crossover | RSI | ||||||
| Stochastic (Fast) Analysis | Neutral | 67.870 | ||||||
| 50-Day MA Analysis | Above 50-Day MA | %K (fast) | ||||||
| 200-Day MA Analysis | Above 200-Day MA | 72.299 | ||||||
| Critical Level Analysis | Broke Above Previous Trend | |||||||
| DAVITA INC (DVA) Seasonality | ||||||||
| Analysis has revealed that with a buy date of March 11 and a sell date of January 17, investors have benefited from a total return of 2822.59% over the last 10 years. This scenario has shown positive results in 8 of those periods. | ||||||||
| Conversely, the best return over the maximum number of positive periods reveals a buy date of March 12 and a sell date of October 5, producing a total return over the same 10-year range of 1484.87% with positive results in 10 of those periods. | ||||||||
| The buy and hold return for the past 10 years was 1020.5%. | ||||||||
| News Headlines for DAVITA INC (DVA) | ||||||||
Health-care Stocks: Health-care shares drop on Obama speech (at MarketWatch) - Mon, 8 Mar 2010 DaVita Delivers 20 Presentations at Annual Dialysis Conference (Business Wire) - Mon, 8 Mar 2010 DAVITA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (EDGAR Online) - Fri, 5 Mar 2010 |
||||||||
| Tech Talk – By The Numbers is a supplement to current offerings from TimingTheMarket.ca and will be offered by Mr. Vialoux following each trading day. | ||||||||
| Disclosure: Mr. Vialoux does not own securities mentioned in this report. | ||||||||
| Disclaimer: Comments and opinions offered in this report at www.timingthemarket.ca are for information only. They should not be considered as advice to purchase or to sell mentioned securities. | ||||||||
| Data offered in this report is believed to be accurate, but is not guaranteed. | ||||||||
Download Link for all stocks:
Tags - Previous posts for stock ticker: AGN, BCR, CI, DVA
Recent Comments